| |
Christopher
A. Girkin, MD, MSPH, is a tenured professor of Ophthalmology
and director of the UAB Glaucoma Service in the Department
of Ophthalmology at Callahan Eye Foundation Hospital. He
completed his ophthalmology residency at The University
of Alabama at Birmingham. He completed a fellowship in
neuro-ophthalmology at Johns Hopkins’ Wilmer Eye
Institute, Baltimore, Maryland, and was a Heed Glaucoma
Fellow at The Shiley Eye Center at the University of California,
San Diego.
Dr. Girkin
has authored or coauthored over 130 journal articles, abstracts,
and book chapters in major ophthalmic publications covering
both neuro-ophthalmology and glaucoma. He has research grant support as primary investigator from Research to Prevent Blindness, Eyesight Foundation of Alabama, Glaucoma Research Foundation, and the National Eye Institute. He has been awarded the American Glaucoma Society Clinician-Scientist Award for 2003 and 2004, the Research to Prevent Blindness Clinician-Scientist Award for 2005, was selected and the EyeSight Foundation of Alabama Eminent Scholar Award for 2007, and received the Ronald Lowe Medal for 2008. He has been selected as one of the “Best Doctors in America” yearly from 2003 to 2008. He has served as an invited lecturer at numerous research and educational events—including recently chairing the AAO Glaucoma Subspecialty Day, and has presented to ophthalmic practitioners and researchers in over 150 venues throughout the United States and abroad. He has also served
as a reviewer for several publications, including the Journal
of Glaucoma, Archives of Ophthalmology, American Journal
of Ophthalmology, and Investigative Ophthalmology and Visual
Sciences. He currently serves on the editorial board for
Focus on Glaucoma and as a guest editorial board member
for Investigative Ophthalmology and Visual Sciences.
Dr Girkin’s
major research focus has developed the first three-dimensional
digital reconstructions of the human optic nerve head.
These unique high-fidelity reconstructions can then be
used to test the hypothesis that variation in 3D laminar
architecture and biomechanical behavior are critical
in determining individual susceptibility to glaucomatous
injury. Specifically, that variation in laminar 3D architecture
is associated with well described risk factors for glaucomatous
disease such as increasing age and African-American ancestry.
|
